A preventive care strategy to reduce moderate or severe acute kidney injury after major surgery (BigpAK-2); a multinational, randomised clinical trial.
Zarbock A, Ostermann M, Forni L, Bode C, Wild L, Putensen C, Roux DP, Martín EE, Arndt C, Rahmel T, de Rosa S, Monard C, Schneider AG, Glass A, Jung-König M, Romagnoli S, Gossage J, Lumlertgul N, Haaker JG, Ripollés-Melchor J, Spadaro S, Siniscalchi A, Futier E, Aupetitgendre L, Bhathal IR, Álvarez RG, Bernard A, Rosenberger P, Wempe C, Sadjadi M, Meersch M, Fischhuber K, Bellomo R, Kellum JA, von Groote T; BigpAK-2 study group.
Zarbock A, et al. Among authors: von groote t.
Lancet. 2025 Dec 13;406(10521):2782-2791. doi: 10.1016/S0140-6736(25)01717-9. Epub 2025 Nov 13.
Lancet. 2025.
PMID: 41242333
Free article.
Clinical Trial.